Abstract: Are FDA Compliance Checks Equitable? a Profile Analysis and Geospatial Analysis (Society for Social Work and Research 27th Annual Conference - Social Work Science and Complex Problems: Battling Inequities + Building Solutions)

All in-person and virtual presentations are in Mountain Standard Time Zone (MST).

SSWR 2023 Poster Gallery: as a registered in-person and virtual attendee, you have access to the virtual Poster Gallery which includes only the posters that elected to present virtually. The rest of the posters are presented in-person in the Poster/Exhibit Hall located in Phoenix A/B, 3rd floor. The access to the Poster Gallery will be available via the virtual conference platform the week of January 9. You will receive an email with instructions how to access the virtual conference platform.

530P Are FDA Compliance Checks Equitable? a Profile Analysis and Geospatial Analysis

Schedule:
Saturday, January 14, 2023
Phoenix C, 3rd Level (Sheraton Phoenix Downtown)
* noted as presenting author
Mariam Rashid, MPH, Doctoral Research Associate, Rutgers University, New Brunswick, NJ
Joseph G.L. Lee, PhD, Associate Dean for Research, ECU College of Health and Human Performance, East Carolina University, NC
Cory Morton, PhD, Assistant Research Professor, Rutgers University, NJ
Kristen Powell, PhD, Assistant Research Professor, Rutgers University, New Brunswick, NJ
Andrew Peterson, PhD, Professor, Rutgers University, NJ
Background: Although tobacco prevention and control efforts have tried to prevent minors from purchasing tobacco, tobacco continues to be a public health epidemic. One such effort is Food and Drug Administration (FDA) compliance checks. From previously published work on tobacco density, studies have found that tobacco density is high among areas of lower socioeconomic status (SES). This study hypothesized, that as tobacco density is higher among lower SES neighborhoods, these neighborhoods were more likely to be included in FDA compliance checks. To examine equity of FDA compliance check coverage, we created profiles to analyze if the FDA compliance checks were being conducted equitably across retailers based on neighborhood characteristics or having equal chance of being checked. This study also hypothesized that non-chain convenience stores will be cited for a violation after a FDA compliance check.

Method: This study used three sources of public data from New Jersey; 1) 2019 licensed tobacco retail outlets, 2) FDA compliance check data from 2019, 3) sociodemographic data from the American Community Survey (ACS). Once these data were matched together and cleaned, a Latent Profile Analysis (LPA) was conducted creating profiles based on tobacco density from census tracts. No previous study has used LPA to examine tobacco density or FDA compliance checks. Regression analyses predicted the likelihood that FDA compliance checks were conducted more in profiles with high tobacco density and in areas of lower socioeconomic demographics. Regression analysis also examined the relationship/predict that non-chain convenience stores are more likely to be cited for a violation from an FDA compliance check than chain convenience stores.

Results: Results of preliminary analysis suggests census tracts can be profiled based on the densities of different types of licensed tobacco retail outlets. And that there are certain profile types are stronger predictors suggesting the likelihood of being part of the FDA compliance checks. The preliminary results also show that profiles made of up census tracks of lower sociodemographics are also more likely to be part of the FDA compliance checks. When examining the likelihood of a violation by store type, preliminary results showed non-chain convenience stores are more likely to be cited for a violation as a result of a FDA compliance check than chain convenience stores.

Conclusions: The results of this study provide some policy implications; the first is to encourage the FDA to use their power to issue more civil money penalties and no-tobacco orders to restrict the access of tobacco among youth, truly exercising the compliance checks as a prevention tool. The second policy recommendation is to suggest that changes to FDA compliance checks to ensure that the FDA checks all areas of the state equally, as tobacco outlets are found across the states throughout multiple profiles regardless of sociodemographics.